Shares of Geron Corporation (NASDAQ: GERN), a biotechnology company focused on developing therapies for cancer, are sinking in today’s trading after the company said that it is ending its imetelstat breast cancer study.
Continue reading Major Gainers and Losers on September 10; GERN, AIG, GMCR, SWHC, BAH, PXP, S